Constellation 3D Announces Appointment of Dr. Jesse Fussell; Former ARDA Director to Join Newly Created Scientific Advisory Board.Business Editors NEW YORK--(BUSINESS WIRE)--May 7, 2001 Constellation 3D, Inc. ("C3D A technology developed at the Turing Institute, Glasgow, Scotland for creating 3D models. Using two cameras to obtain stereo images, C3D turns subjects into 3D models in AutoCAD, 3D Studio and virtual reality formats for Internet use. ") (Nasdaq/NMS: CDDD CDDD Customer Desired Due Date CDDD Construction and Demolition Diversion Deposit CDDD Component Detailed Design Document ), developer of Fluorescent Multilayer Discs (FMD FMD foot-and-mouth disease. ) and Cards (FMC See fixed mobile convergence. ), today announced the appointment of Dr. Jesse Fussell and the formation of a Scientific Advisory Board which will supervise the FMD/C standardization program. Dr. Fussell was the founder and first Director of ARDA Noun 1. ARDA - an agency of the Intelligence Community that conducts advanced research and development related to information technology Advanced Research and Development Activity (Advance Research and Development Activity), an information technology agency of the US government. He was responsible for the funding and incubation of many innovative technology companies under ARDA's operating mandate. Further, Dr. Fussell directed the communications science research division of the NSA (National Security Agency) and has been involved in furthering relationships between the high technology industry and US government for over 20 years. "C3D's revolutionary Fluorescent Multilayer technology has tremendous potential and I look forward to helping ensure that its value is realized in commercial and government applications," said Dr. Fussell. "Dr. Fussell is a respected industry leader and we are very excited to have him join us," said C3D President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Dr. Eugene Levich. "In addition, the establishment of a Scientific Advisory Board gives us a vehicle to draw from a vast knowledge base of industry experts from outside of the Company. The Board's first task will be to supervise the implementation of a comprehensive FMD standardization program." Constellation 3D, Inc. The Company is the worldwide leader in the development of high capacity Fluorescent Multilayer Disc and Card (FMD/C) technology. Constellation 3D holds or has made applications for over 80 worldwide patents in the field of optical data storage, and is supported by 65 scientists. Headquartered in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. , the Company has additional offices and laboratories in Massachusetts, Israel and Russia. More information is available at www.c-3d.net. Safe Harbor Statement Statements contained in the news release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such forward-looking statements as "I look forward to helping ensure that its value is realized in commercial and government applications" and "C3D's revolutionary fluorescent multilayer technology has tremendous potential" are subject to risks and uncertainties including competition, ongoing discussions with product and equipment manufactures, and technological advances, and "Risk Factors" as stated in recent SEC filings, which may cause actual results to differ materially from expected results. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion